Increase in single-tablet regimen use and associated improvements in adherence-related outcomes in HIV-infected women.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Author
Hanna, David BHessol, Nancy A
Golub, Elizabeth T
Cocohoba, Jennifer M
Cohen, Mardge H
Levine, Alexandra M
Wilson, Tracey E
Young, Mary
Anastos, Kathryn
Kaplan, Robert C
Journal title
Journal of acquired immune deficiency syndromes (1999)Date Published
2014-04-15Publication Volume
65Publication Issue
5Publication Begin page
587Publication End page
96
Metadata
Show full item recordAbstract
Introduction: The use of single-tablet antiretroviral therapy (ART) regimens and its implications on adherence among HIV-infected women have not been well described.Methods: Participants were enrolled in the Women's Interagency HIV Study, a longitudinal study of HIV infection in US women. We examined semiannual trends in single-tablet regimen use and ART adherence, defined as self-reported 95% adherence in the past 6 months, during 2006-2013. In a nested cohort study, we assessed the comparative effectiveness of a single-tablet versus a multiple-tablet regimen with respect to adherence, virologic suppression, quality of life, and AIDS-defining events, using propensity score matching to account for demographic, behavioral, and clinical confounders. We also examined these outcomes in a subset of women switching from a multiple- to single-tablet regimen using a case-crossover design.
Results: We included 15,523 person-visits, representing 1727 women (53% black, 29% Hispanic, 25% IDU, median age 47). Use of single-tablet regimens among ART users increased from 7% in 2006% to 27% in 2013; adherence increased from 78% to 85% during the same period (both P < 0.001). Single-tablet regimen use was significantly associated with increased adherence (adjusted risk ratio: 1.05; 95% confidence interval: 1.03 to 1.08) and virologic suppression (risk ratio: 1.06; 95% confidence interval: 1.01 to 1.11), while associations with improved quality of life and fewer AIDS-defining events did not achieve statistical significance. Similar findings were observed among the subset of switchers.
Conclusions: Single-tablet regimen use was associated with increased adherence and virologic suppression. Despite this, 15% of women prescribed ART were still not optimally adherent; additional interventions are needed to maximize therapeutic benefits.
Citation
Hanna DB, Hessol NA, Golub ET, Cocohoba JM, Cohen MH, Levine AM, Wilson TE, Young M, Anastos K, Kaplan RC. Increase in single-tablet regimen use and associated improvements in adherence-related outcomes in HIV-infected women. J Acquir Immune Defic Syndr. 2014 Apr 15;65(5):587-96. doi: 10.1097/QAI.0000000000000082. PMID: 24326606; PMCID: PMC3999284.DOI
10.1097/QAI.0000000000000082ae974a485f413a2113503eed53cd6c53
10.1097/QAI.0000000000000082
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International
Related articles
- Odds of Viral Suppression by Single-Tablet Regimens, Multiple-Tablet Regimens, and Adherence Level in HIV/AIDS Patients Receiving Antiretroviral Therapy.
- Authors: Sutton SS, Magagnoli J, Hardin JW
- Issue date: 2017 Feb
- Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy.
- Authors: Benning L, Mantsios A, Kerrigan D, Coleman JS, Golub E, Blackstock O, Konkle-Parker D, Philbin M, Sheth A, Adimora AA, Cohen MH, Seidman D, Milam J, Kassaye SG, Taylor T, Murray M
- Issue date: 2020 Jul 25
- Impact of Pill Burden on Adherence, Risk of Hospitalization, and Viral Suppression in Patients with HIV Infection and AIDS Receiving Antiretroviral Therapy.
- Authors: Scott Sutton S, Magagnoli J, Hardin JW
- Issue date: 2016 Apr
- Real-world adherence and persistence for newly-prescribed HIV treatment: single versus multiple tablet regimen comparison among US medicaid beneficiaries.
- Authors: Cohen J, Beaubrun A, Bashyal R, Huang A, Li J, Baser O
- Issue date: 2020 Apr 1
- Stable Caloric Intake and Continued Virologic Suppression for HIV-Positive Antiretroviral Treatment-Experienced Women After Switching to a Single-Tablet Regimen of Emtricitabine, Rilpivirine, and Tenofovir Disoproxil Fumarate.
- Authors: Menezes P, Mollan K, Hoffman E, Xie Z, Wills J, Marcus C, Rublein J, Hudgens M, Eron JJ Jr
- Issue date: 2018 Jun